Figure 1. In vitro blood formation of Fanconi anemia induced pluripotent stem cells. (1) Direct reprogramming of human FA fibroblasts yields disease-specific iPSC containing patient gene mutations. (2) Directed differentiation of iPSC results in hematopoietic progenitor cells, enabling disease modeling and chemical screens.